DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Marc Feldmann
Marc Feldmann
Cytokines MONTRÉAL 2008
The Role of Polyadenylation in the Induction of Inflammatory Genes
2008-05-13-Professors Marc Feldmann and Sir Ravinder Maini
The Recent History of Tumour Necrosis Factor (Tnf)
Pnas11052ackreviewers 5098..5136
2020 Annual Report
Anti-TNF Therapy from the Bench to the Clinic
Trial Please Esteemed Panel of Researchers
Springer Book Archives Seite 823 P-Adic Numbers 1997 1984
100902 PI Preisverleihung ESP 2010 Eng
Michel Foucault Ronald C Kessler Graham Colditz Sigmund Freud
Past, Present and Future
Strengthening Science Across Europe the EMBO Strategy
EMBO Facts & Figures
Arthur Weiss, MD, Ph.D. Position: Ephraim P
EULAR Research Center Database London Director of the Research
Professor Sir Marc Feldmann
A Conversation with Marc Feldmann
Top View
Role in Cocaine Addiction Versus Maternal Immune Activation
Accumulating Evidence Suggests Anti-TNF Therapy Needs to Be Given Trial Priority in COVID-19 Treatment
Kennedy Institute Report 2016 Kennedy Institute Report 2016 3 Director's Message
Trials of Anti-Tumour Necrosis Factor Therapy for COVID-19 Are Urgently Needed
The Development of Anti-TNF Therapy of Rheumatoid Arthritis
Pnas11052ackreviewers 5098..5136
Defying the Virus Sarah-Maria Fendt and Markus Ralser Journal
A Conversation with Marc Feldmann, Jacques Miller, and Max Cooper
Full Stage Application to Become an AHSC
(12) United States Patent (10) Patent No.: US 7,838,489 B2 Feldmann Et Al
Michel Foucault Ronald C Kessler Graham Colditz Sigmund Freud
100413 CV Marc Feldmann Eng Final
Targeting Cytokines in Disease
Wellcome Trust Grants Awarded 2014/15 1 October 2014–30 September 2015 Key to Panels (Column O)
Reproduction Number (R) and Growth Rate (R) of the COVID-19 Epidemic In
What Lessons Has It Anti-TNF Therapy, from Rationale To
From Bratislava to New York: a Scientist's Tale Sir Marc Feldmann
Arthritis Therapy in Rheumatoid Α Anti-TNF
2014 Annual Report
Collagen-Induced Arthritis and Comparison and IL-1 Blockade in Α
Institution: Imperial College London
EMBO Facts & Figures 2019
TNF Defined As a Therapeutic Target for Rheumatoid Arthritis and Other Autoimmune Diseases